Turning the clock: mRNA-encoded thymic factors restore aged immunity

In a recent study published in Nature by Friedrich et al. demonstrate that mRNA-encoded delivery of DLL1, FLT3L, and IL-7 to the liver rejuvenates aged immunity, improving vaccine responses and antitumor immunity in mice. 1 This work introduces a safe, transient approach to reversing immunosenescence by reconstituting a youthful signaling niche without inducing autoimmunity as shown in Fig. 1 . Fig. 1 The alternative text for this image may have been generated using AI. Full size image Hepatic reconstitution of thymic trophic factors rejuvenates aged immunity. a Ageing is characterized by thymic involution, diminished production of key trophic factors (DLL1, FLT3L, IL-7), and a systemic decline in their signaling. This leads to reduced naïve T cell output, impaired cDC1 function, and an accumulation of exhausted-like T cells, resulting in poor vaccine responses and ineffective antitumor immunity. b mRNA-based hepatic reconstitution. Liver-targeted lipid nanoparticles (LNPs) deliver mRNAs encoding DLL1, FLT3L, and IL-7 (DFI) to hepatocytes. This transiently reprograms the liver into a bio-factory, producing surface-bound DLL1 and secreting FLT3L and IL-7 into the circulation. c Multi-organ immune rejuvenation. The reconstituted factors drive a coordinated immune recovery: (1) expansion of bone marrow common lymphoid progenitors (CLPs); (2) enhanced thymopoiesis and increased output of recent thymic emigrants (RTEs); (3) replenishment of the peripheral naïve T cell pool; and (4) expansion and functional boost of cDC1s. This rejuvenated immune landscape restores antigen-specific CD8⁺ T cell responses and synergizes with immune checkpoint blockade (e.g., anti-PD-L1) to enhance antitumor immunity. d The safety profile: Transient and self-limited. The therapeutic effects are reversible upon cessation of treatment. The mRNA-LNP platform avoids the severe inflammation and toxicity associated with recombinant cytokine therapy and does not break peripheral or central self-tolerance, preventing autoimmunity. Figure created with BioRender.com